Gwajin Antigen shine sabon samfurin Labcorp don yaƙar COVID-19 a kowane mataki daga gwaje-gwajen bincike zuwa gwajin asibiti da sabis na rigakafi.
Burlington, North Carolina-(KUSAUTAR WIRE)-Labcorp (NYSE:LH), babban kamfanin kimiyyar rayuwa na duniya, a yau ya sanar da ƙaddamar da wani gwajin neoantigen na dakin gwaje-gwaje wanda zai taimaka wa likitoci su tantance ko mutum ya kamu da cutar ta COVID-19.
Ana iya samar da gwajin antigen da DiaSorin ya kirkira ga marasa lafiya bisa umarnin likita kuma ana iya gwadawa don sanin ko har yanzu mutum yana kamuwa da COVID-19 kuma yana iya yaduwa.Likita ko wani mai ba da sabis na likita ne ke yin gwajin ta hanyar amfani da hanci ko hancin hanci don tattara samfurin, sannan Labcorp ya ɗauka kuma ya sarrafa shi.Za a iya samun sakamakon a cikin sa'o'i 24-48 akan matsakaici bayan ɗauka.
Dr. Brian Caveney, babban jami'in kula da lafiya kuma shugaban Labcorp Diagnostics, ya ce: "Wannan sabon gwajin rigakafin antigen wani misali ne na jajircewar Labcorp na samarwa mutane bayanan da suke bukata don yanke shawara mai mahimmanci na kiwon lafiya."Har yanzu ana la'akari da gwajin PCR don gano ma'aunin gwal na COVID-19, saboda suna iya gano mafi ƙarancin ƙwayar cuta.Koyaya, gwajin antigen wani kayan aiki ne wanda zai iya taimaka wa mutane su fahimci ko har yanzu suna iya ɗaukar kwayar cutar ko kuma za su iya ci gaba da aiki da ayyukan rayuwa cikin aminci.”
Dangane da Cibiyoyin Kula da Cututtuka da Cututtuka (CDC), ana iya amfani da gwajin antigen a cikin dabarun gwaji iri-iri don amsa cutar ta COVID-19 da taimakawa tantance ko mutumin da aka gano yana da COVID-19 har yanzu yana kamuwa da cuta.
Labcorp ya ci gaba da ba da shawara ga mutane da su bi ka'idodin kiwon lafiya, gami da sanya abin rufe fuska a wuraren jama'a, nisantar jama'a, wanke hannu akai-akai da guje wa manyan gungun mutane, da karɓar rigakafin COVID-19 yayin da ake samun wadatuwa kuma jagororin CDC sun faɗaɗa zuwa ƙwararrun mutane. .Don ƙarin bayani game da amsawar COVID-19 na Labcorp da zaɓuɓɓukan gwaji, da fatan za a ziyarci microsite na Labcorp's COVID-19.
An ba da gwajin rigakafin DiaSorin LIAISON® SARS-CoV-2 Ag ga kasuwannin Amurka bayan sanar da Hukumar Abinci da Magunguna ta Amurka (FDA) daidai da ka'idar gwajin cutar Coronavirus ta FDA ta 2019 a ranar 26 ga Oktoba, 2020. An sake shi yayin “Gaggawa Lafiyar Jama’a” (Buguwar Bita) wanda aka saki ranar 11 ga Mayu, 2020.
Labcorp babban kamfani ne na kimiyyar rayuwa na duniya wanda ke ba da mahimman bayanai don taimakawa likitoci, asibitoci, kamfanonin harhada magunguna, masu bincike da marasa lafiya su yanke shawara a sarari da ƙarfin gwiwa.Ta hanyar binciken mu mara misaltuwa da ƙarfin haɓakar ƙwayoyi, za mu iya ba da fahimta da haɓaka sabbin abubuwa don inganta lafiya da inganta rayuwa.Muna da ma'aikata sama da 75,000 kuma muna ba da sabis ga abokan ciniki a cikin ƙasashe sama da 100.Labcorp (NYSE: LH) ta ba da rahoton cewa kudaden shiga na shekara ta 2020 zai zama dala biliyan 14.Koyi game da Labcorp akan www.Labcorp.com, ko bi mu akan LinkedIn da Twitter @Labcorp.
Wannan sakin labaran ya ƙunshi maganganun sa ido, gami da amma ba'a iyakance ga gwajin dakin gwaje-gwaje na asibiti ba, yuwuwar fa'idodin kayan tattarawar gida na COVID-19, da damarmu don cutar ta COVID-19 da ci gaban gaba.Kowace sanarwa mai hangen nesa na iya canzawa saboda dalilai masu mahimmanci daban-daban, waɗanda yawancinsu sun wuce ikon kamfani, gami da amma ba'a iyakance ga ko martaninmu ga cutar ta COVID-19 zai tabbatar da tasiri ba, da tasirin COVID-19 A cikin kasuwancinmu. da yanayin kuɗi da kuma yanayin tattalin arziki, kasuwanci da kasuwa gabaɗaya, halayen gasa da sauran sauye-sauyen da ba a zata ba da rashin tabbas a kasuwa gabaɗaya, canje-canje a cikin ƙa'idodin gwamnati (ciki har da gyare-gyaren kula da lafiya, yanke shawarar siyan abokin ciniki, gami da abinci da canjin magani) a cikin Dokokin masu biyan buƙatu ko manufofi, wasu halaye marasa kyau na gwamnati da masu biyan kuɗi na ɓangare na uku, bin ka'idoji da sauran buƙatu, batutuwan aminci na haƙuri, jagororin gwaji ko canje-canjen da aka gabatar, tarayya, jiha, da ƙaramar gwamnati game da COVID-19 annoba ta haifar da sakamako mara kyau a cikin manyan lamuran shari'a kuma ya kasa kulawa ko haɓaka abokin cinikiationships ships ps: Muna da ikon haɓakawa ko samun sabbin samfura da daidaitawa ga canje-canjen fasaha, fasahar bayanai, tsarin ko gazawar tsaro na bayanai, da ikon dangantakar ma'aikata.Wadannan abubuwan sun shafi wasu lokuta, kuma a nan gaba (tare da wasu dalilai) na iya yin tasiri ga ikon kamfani na aiwatar da dabarun kasuwancin kamfanin, kuma ainihin sakamakon zai iya bambanta da abin da aka ba da shawara a cikin waɗannan maganganun sa ido.Don haka, ana gargadin masu karatu da kar su dogara ga duk wani kalami na sa ido.Ko da tsammanin sa ya canza, kamfanin ba shi da alhakin samar da kowane sabuntawa ga waɗannan maganganun sa ido.Duk irin wadannan kalamai masu sa ido duk suna da nasaba da wannan sanarwa ta gargadi.Rahoton shekara-shekara kan sabon Form 10-K na kamfanin da kuma Form 10-Q na gaba (ciki har da ƙarƙashin taken “Haɗarin Abubuwan Haɗari” a kowace harka) da “Sauran takaddun da kamfani ya gabatar ga SEC.
Lokacin aikawa: Fabrairu-19-2021